Earnhardt Lisa D's Form 4 filing
Abbott Laboratories (ABT) · filed May 8, 2024
- Accession no.
- 0001415889-24-012624
- Filed
- May 8, 2024
- Trade date
- May 7, 2024
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $2.43M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Earnhardt Lisa DCIK 0001530893 | Officer (EXECUTIVE VICE PRESIDENT) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 7, 2024 | Common shares without par value | SSaleDisposed | −22,852 | $106.25 | −$2,428,025 | 61,462 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.